Background Pain is associated with shorter survival in non-small cell lung cancer (NSCLC).
Lung cancer cells express opioid receptors. Opioids promote angiogenesis, tumour growth …

Background: Preclinical studies show that opioids promote angiogenesis, tumor
progression, and metastasis, resulting in shorter survival. Objective: To explore whether …

Opioids are commonly used for postoperative pain control in cancer patients. In addition to
pain control, an association between opioid use and long-term oncologic outcomes, such as …

Background The impact of opioid analgesic use before cancer diagnosis on survival in
patients with chronic pain is unclear. Therefore, we designed a propensity score-matched …

Preclinical studies have demonstrated that opioid receptor agonists increase the rate of non‐
small cell lung cancer (NSCLC) growth and metastasis. Following institutional review board …

Background Evidence suggests that opioid-sparing anaesthetic techniques might be
associated with increased cancer-free postoperative survival. This could be related to …

Opinion statement Opioids are the gold standard for the treatment of cancer-related pain.
Preclinical studies have associated opioids with cancer progression and overall survival. In …

PURPOSE Pain is a common and feared symptom for patients with incurable cancer.
Comprehensive assessment provides the foundation for effective pain management, and …

1. Background Traditionally, opioids have been considered the sine qua non of treating
postsurgical pain. However, opioid use is associated with several aspects of poor health …

Opioids are important in the management of pain in patients with cancer. Clinicians and
patients are sometimes concerned about the effect of opioids on survival, which might …